Hyun Seok Lee

Hyun Seok Lee

Auto-generated profile, based on publicly available information

Hyun Seok Lee

Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2014 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
YKY. H. Kwon
Y. H. Kwon
JHJ. Heo
J. Heo
HLH. S. Lee
H. S. Lee
CCC. M. Cho
C. M. Cho
SJSeong Woo Jeon
Seong Woo Jeon
Summary: Background: Whether the incidence of metachronous gastric dysplasia and cancer could be decreased by eradication of Helicobacter pylori after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC).Aim: To compare the incidence of metachronous gastric lesion in the eradicated group and the persistent group. Second end point is to evaluate the risk factors for metachronous gastric lesions after ESD for EGC.Methods: In a single centre, between May 2007 and May 2010, the patients who had evidence of H. pylori infection at the time of ESD for EGC were included, and the follow‐up data were analysed retrospectively.Results: We enrolled 283 patients who have shown H. pylori infection at the time of ESD for EGC. Successful eradication was achieved for 214 patients (75.6%) (Eradicated group), and 69 patients (24.4%) showed persistent H. pylori infection (Persistent group). Metachronous gastric lesions developed in 13 (18.8%) in the persistent group and 18 (8.4%) in the eradicated group (P = 0.016). In the ≥60‐year‐old group, the cumulative incidence of metachronous gastric cancer showed a significant increase (P = 0.012). Cumulative hazard ratio of subsequent gastric metachronous lesions differed between the eradication group and the persistent infection group (OR = 2.322, 95% CI = 1.136–4.744, P = 0.021), and ≥60 age at the time of endoscopic resection (OR = 2.803, 95% CI = 1.207–6.509, P = 0.016).Conclusions: Both persistent H. pylori infection and old age (≥60) are independent risk factors for the increased incidence of metachronous gastric cancer.

30 March 2017 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
KSKi-Nam Shim
Ki-Nam Shim
SJSeong Ran Jeon
Seong Ran Jeon
HJHyun Joo Jang
Hyun Joo Jang
JKJinsu Kim
Jinsu Kim
YLYun Jeong Lim
Yun Jeong Lim
KGKorean Gut Image Study Group
Korean Gut Image Study Group
Capsule endoscopy (CE) enables evaluation of the entire mucosal surface of the small bowel (SB), which is one of the most important steps for evaluating obscure gastrointestinal bleeding. Although the diagnostic yield of SB CE depends on many clinical factors, there are no reports on quality indicators. Thus, the Korean Gut Image Study Group (KGISG) publishes an article titled, "Quality Indicators for Small Bowel Capsule Endoscopy" under approval from the Korean Society of Gastrointestinal Endoscopy (KSGE). Herein, we initially identified process quality indicators, while the structural and outcome indicators are reserved until sufficient clinical data are accumulated. We believe that outcomes of SB CE can be improved by trying to meet our proposed quality indicators.

21 March 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
EKEun Soo Kim
Eun Soo Kim
GSGeun Am Song
Geun Am Song
KCKwang Bum Cho
Kwang Bum Cho
KPKyung Sik Park
Kyung Sik Park
KKKyeong Ok Kim
Kyeong Ok Kim
HKHyun Jin Kim
Hyun Jin Kim
AIM: To evaluate the incidence and risk factors of Korean tuberculosis (TB) infection in patients with inflammatory bowel disease (IBD) undergoing anti-TNF treatment. METHODS: The data of IBD patients treated with anti-TNFs in 13 tertiary referral hospitals located in the southeastern region of Korea were collected retrospectively. They failed to show response or were intolerant to conventional treatments, including steroids or immunomodulators. Screening measures for latent TB infection (LTBI) and the incidence and risk factors of active TB infection after treatment with anti-TNFs were identified. RESULTS: Overall, 376 IBD patients treated with anti-TNF agents were recruited (male 255, mean age of anti-TNF therapy 32.5 ± 13.0 years); 277 had Crohn’s disease, 99 had ulcerative colitis, 294 used infliximab, and 82 used adalimumab. Before anti-TNF treatment, screening tests for LTBI including an interferon gamma release assay or a tuberculin skin test were performed in 82.2% of patients. Thirty patients (8%) had LTBI. Sixteen cases of active TB infection including one TB-related mortality occurred during 801 person-years (PY) follow-up (1997.4 cases per 100000 PY) after anti-TNF treatment. LTBI (OR = 5.76, 95%CI: 1.57-21.20, P = 0.008) and WBC count < 5000 mm3 (OR = 4.5, 95%CI: 1.51-13.44, P = 0.007) during follow-up were identified as independently associated risk factors. CONCLUSION: Anti-TNFs significantly increase the risk of TB infection in Korean patients with IBD. The considerable burden of TB and marked immunosuppression might be attributed to this risk.

21 September 2017 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
ESEun Mi Song
Eun Mi Song
HYHyo-Joon Yang
Hyo-Joon Yang
HLHyun Seok Lee
Hyun Seok Lee
JCJae Myung Cha
Jae Myung Cha
HKHyun Gun Kim
Hyun Gun Kim
JBJeong-Sik Byeon
Jeong-Sik Byeon

10 April 2019 in Helicobacter
Verified
Journal Article
Open access
PDF file
YKYong Hwan Kwon
Yong Hwan Kwon
SJSeong Woo Jeon
Seong Woo Jeon
SNSu Youn Nam
Su Youn Nam
HLHyun Suk Lee
Hyun Suk Lee
JPJi Hey Park
Ji Hey Park
Background: As the prevalence of antibiotic resistance is increasing, the effectiveness of traditional Helicobacter pylori (H pylori) therapies is gradually declining. We aimed to evaluate the efficacy of tailored therapy (dual priming oligonucleotide [DPO]‐based multiplex PCR) and previous antibiotic exposure survey predicting for antibiotic resistance.Materials and Methods: Patients with H pylori infection who did not receive previous treatment were enrolled. The patients were divided into four groups (no resistance [NR] group, clarithromycin resistance [CLA‐R] group, metronidazole‐resistant [MET‐R] group, and CLA‐ and MET‐resistant [Dual‐R] group) based on the results of dual priming oligonucleotide (DPO) polymerase chain reaction (PCR) and previous antibiotic exposure survey, and they were treated with tailored therapy based on antibiotic susceptibility.Results: Consecutive patients were distributed in the NR (n = 36, 70.6%), CLA‐R (n = 9, 17.6%), and suspected MET‐R (n = 6, 11.8%) group. The overall intention‐to‐treat/per‐protocol eradication rate (ITT/PP) was 92.2%/94.0%. In the subgroup analysis, the ITT and PP of the NR, CLA‐R, and MET‐R groups were 94.4%/94.4%, 77.8%/87.5%, and 100.0%/100.0%, respectively. Total of 31 patients in all subgroups were evaluated for antibiotic resistance; five (16.1%), two (6.5%), and three (9.7%) participants showed CLA, MET, and dual resistance in culture‐based susceptibility test. Compared with culture‐based MIC test, the accuracy of DPO‐based multiplex PCR in determining CLA resistance was 90.3%, while the accuracy of survey in determining MET resistance was only 77.4%.Conclusion: A tailored therapy based on DPO‐PCR and history of previous antibiotic use is useful in clinical practice and well correlated with culture‐based susceptibility test.

31 July 2018 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
SNSeung-Joo Nam
Seung-Joo Nam
HLHyun Seok Lee
Hyun Seok Lee
Yun Jeong LimYun Jeong Lim
Yun Jeong Lim
The clinical indication for capsule endoscopy has expanded from small bowel evaluation to include esophagus or colon evaluation.Nevertheless, the role of capsule endoscopy in evaluation of the stomach is very limited because of the large volume and surface.However, efforts to develop an active locomotion system for capsule manipulation in detailed gastric evaluation are ongoing, becausethe technique is non-invasive, convenient, and safe, and requires no sedation. Studies have successfully reported gastric evaluation usinga magnetic-controlled capsule endoscopy system. Advances in technology suggest that capsule endoscopy will have a major role notonly in the evaluation of gastric disorders but also in the pathologic diagnosis, intervention, and treatment of any gastrointestinal tractdisorder.